| 2416170-29-9 | 1,1-Dimethylethyl 4-[1-(6-chloro-1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-5-hydroxy-1H-pyrazol-3-yl]-1-piperidinecarboxylate |
| 2736513-26-9 | 7-(4-Chlorobutoxy)-3,4-dihydro-1-[4-[(1,2,3,4-tetrahydro-2-oxo-7-quinolinyl)oxy]butyl]-2(1H)-quinolinone |
| 1190359-56-8 | NA |
| 2132412-25-8 | Methyl 2-[[2-(1-methoxy-1H-indol-3-yl)acetyl]amino]benzoate |
| 1249400-33-6 | 2-(Ethylamino)-N-(1-methylethyl)benzamide |
| 2797066-35-2 | B-[(1S)-3-Amino-3-oxo-1-[(1-oxo-4-phenylbutyl)amino]propyl]boronic acid |
| 2094630-35-8 | 3,3′-Methylenebis[5,7-difluoro-1H-indole] |
| 2227017-46-9 | 5-Chloro-N-[4-(hydroxymethyl)phenyl]-3-(phenylmethyl)-1H-indole-2-carboxamide |
| 1111501-38-2 | (1,4-Dihydro-4-oxo-5-phenylthieno[2,3-d]pyrimidin-2-yl)methyl 2,3-dihydro-3-oxo-4H-1,4-benzoxazine-4-propanoate |
| 2322365-47-7 | N-[3-[[6-Bromo-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-3H-imidazo[4,5-b]pyridin-7-yl]amino]propyl]cyclopentanecarboxamide |
| 2514958-62-2 | Prinomastat Impurity 18 |
| 426224-45-5 | ACAi-028 |
| 1643806-94-3 | BC-N102 |
| 2379645-28-8 | FT108 |
| 1210803-60-3 | GPR183 antagonist SAE-1 |
| 2007955-25-9 | IRAP-IN-1 |
| 1049809-89-3 | JNJ-39641160 |
| 1360905-04-9 | MU1700 |
| 1313034-82-0 | PKM-833 |
| 1962140-61-9 | PTC-672 |
| 2441748-86-1 | SSCI-2 |
| 2760195-67-1 | SYHA1815 |
| 2064106-48-3 | USP inhibitor 2 |
| 2750799-11-0 | NHS-SS-Ac |
| 1682661-49-9 | ODN 24991 |
| 2766493-12-1 | CL4F8-6 |
| 2031162-89-5 | DW0254 |
| 2212714-60-6 | ASP9822 |
| 2714478-83-6 | CCR2 Covalent-IN-14 |
| 1809980-64-0 | CTN1122 |
| 2241724-59-2 | EMU-116 |
| 2247103-43-9 | Hv1 inhibitor HIF |
| 2375674-19-2 | PD-L1 inhibitor 4 |
| 1292359-62-6 | RS-1748 |
| 1613383-99-5 | SW IV-134 |
| 2067331-84-2 | UCHL1 inhibitor 27 |
| 2408587-59-5 | ZJU-37 |
| 2456476-47-2 | BBR-BODIPY |
| 1217643-87-2 | (Rac)-SNC80 |
| 2642181-22-2 | TP0597850 |
| 2244715-87-3 | BP Lipid 142 |
| 1393899-47-2 | AS2690168 |
| 2760692-58-6 | DK1-04e |
| 2685738-33-2 | ER-001259851-000 |
| 1542130-29-9 | Hsp90 inhibitor 5b |
| 252949-96-5 | MMV084978 |
| 2254433-37-7 | NLRP3-IN-3 |
| 1612779-02-8 | QZN 34 |
| 2227427-47-4 | UAMC-03011 |
| 2409960-02-5 | p62-ZZ ligand YOK-1304 |
| 2098799-79-0 | (S,R,S)-AHPC-O-PEG1-propargyl |
| 183283-19-4 | EDMPC |
| 2157489-64-8 | BP Lipid 126 |
| 2036272-94-1 | BP Lipid 226 |
| 2704616-38-4 | CFT-14441 |
| 2727084-00-4 | CXF-009 |
| 2222998-52-7 | FT234 |
| 1561819-01-9 | IRBM6 |
| 2411771-94-1 | JS24 |
| 1883730-99-1 | LMP517 |
| 852863-80-0 | Myomed-946 |
| 1881281-01-1 | PTC-847 |
| 2225879-93-4 | STAT3 inhibitor N4 |
| 2383037-14-5 | ZHAWOC21026 |
| 2669785-76-4 | JPS014 |
| 2734870-15-4 | Emitasvir diphosphate |
| 1802499-21-3 | TAM558 |
| 2756323-15-4 | MS934 |
| 290309-82-9 | 2-ethyl-1(1H-imidazol-1-yl)butan-1-one |
| 2168981-55-1 | 2-amino-4-ethoxy-5-nitrobenzoic acid |
| 1822484-24-1 | 3-Phenyl-pyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester |
| 1057679-72-7 | 3-(2-Bromo-5-fluoro-phenyl)-propylamine |
| 1894246-26-4 | NA |
| 2940964-47-4 | 6,6-difluoroazepan-4-ol |
| 2095495-68-2 | WTXT-2 |
| 2375367-81-8 | (3,4-difluoro-5-(trimethylstannyl)thiophen-2-yl)trimethylsilane |
| 1260675-80-6 | 2,3-Dihydrobenzo[b]furan-5-carbaldehyde |
| 1265637-80-6 | 3,6-bis(furan-2-yl)-2,5-dihydro-2,5-bis(2-hexyldecyl)pyrrolo[3,4-c]pyrrolo-1,4-dione |
| 2751557-35-2 | (1R)-1,3-Dihydro-isoindole-1,2-dicarboxylic acid 2-(9H-fluoren-9-ylmethyl) ester |
| 1030006-11-1 | 1H-Pyrrole-3-methanamine,5-(3-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-,hydrochloride(1:1) |
| 2921961-53-5 | (S)-5-fluoro-3-methylbenzo[c][1,2]oxaborol-1(3H)-ol |
| 1422451-98-6 | 5,10-bis-(9-heptadecyl)-5,10-dihydroindolo[3,2-b]indole |
| 890936-08-0 | 5-bromo-5''-methyl-2,2':6',2''-terpyridine |
| 2883585-24-6 | 5-Bromo-4-(4-chlorothiophen-2-yl)thiazol-2-amine |
| 57679-22-8 | NA |
| 1266379-36-5 | 3,4-dibromo-2'-methylbiphenyl |
| 928324-69-0 | 3-Pyridinesulfinicacid,5-chloro- |
| 674786-24-4 | Methyl 3,4,6-trimethoxy-5-oxo-5H-benz
o[7]annulene-8-carboxylate |
| 1861927-08-3 | Oxetane-3-carboxylic acid methylamide |
| 2378468-57-4 | 9-(4-(pyridin-4-yl)phenyl)-9H-carbazole |
| 1505952-04-4 | 2-Trifluoromethyl-oxazole-5-carbonitrile |
| 1159099-41-8 | (3R,5R)-4,4-difluoro-5-(hydroxymethyl)piperidin-3-ol |
| 108921-80-8 | 1-((Phenylthio)methyl)pyridin-1-ium chloride |
| 2176490-05-2 | LPDA-3 |
| 2055140-21-9 | 2,5-dibromo-3,4-dimethoxyselenophene |
| 2005478-89-5 | Adenosine, 5′→P′-ester with [P′(R)]-thiodiphosphoric acid ((HO)2P(O)OP(O)(OH)(SH)), sodium salt (1:3) |
| 35892-95-6 | 9H-Purine, 9-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-, tetrasodium salt |
| 868613-68-7 | 1,3-Dihydro-4-(2-hydroxyphenyl)-2H-1,5-benzodiazepine-2-thione |
| 1865202-65-8 | 4-Acetyl-2-fluorobenzamide |
| 90690-76-9 | N-(3-Hydroxypropyl)-4-nitrobenzamide |